This inventor holds 23 USPTO granted patents and 10 published patent applications and 2 EPO patents. Top assignees: Bial - R&d Investments, S.a., Lysosomal Therapeutics Inc., X4 Pharmaceuticals, Inc.. Active years: 2017-2024.
Location History:
- L'etsang-du-Nord, CA (2020)
- Bellingham, WA (US) (2020 - 2022)
- L'etang-Du-Nord, CA (2017 - 2024)
Company Filing History:
9 out of 10 
6 out of 7 
5 out of 17 Years Active: 2017-2024
Title: **Elyse Marie Josee Bourque: Innovator in Pharmaceutical Compounds**
Introduction
Elyse Marie Josee Bourque is a remarkable inventor based in L'etang-du-Nord, CA. With an impressive portfolio of 23 patents, Bourque has made significant contributions to the field of medicine, particularly in developing treatments for various medical disorders.
Latest Patents
Among her latest innovations are the patents titled "Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators" and "Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders." These inventions provide a novel class of compounds, namely substituted pyrazolo[1,5-a]pyrimidinyl carboxamide and related organic compounds, specifically targeting the treatment of disorders such as Gaucher disease, Parkinson's disease, Lewy body disease, dementia, and multiple system atrophy. The patents describe various exemplary compounds, including 2-heterocyclyl-4-alkyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide and 5,7-dimethyl-N-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide. The methodologies outlined in her patents expand the therapeutic options available for these critical health challenges.
Career Highlights
Elyse Marie Josee Bourque has worked with notable companies in the pharmaceutical industry, including Bial—r&d Investments, S.A. and Lysosomal Therapeutics Inc. Her work has consistently centered around innovative approaches to drug development, focusing on enhancing the efficacy of treatments for chronic and complex diseases.
Collaborations
Throughout her career, Bourque has collaborated with esteemed professionals such as Renato T. Skerlj and Peter T. Lansbury. These collaborations have further advanced her research and development efforts, contributing to her reputation as a leading innovator in her field.
Conclusion
Elyse Marie Josee Bourque exemplifies the spirit of innovation, making substantial strides in the development of treatments for serious medical conditions. Her work continues to inspire and impact the pharmaceutical landscape, paving the way for future advancements in medical therapies.